Concepedia

Agueda Santana

AS

3

Publications

222

Citations

3

H-Index

2008

Active since

Affiliations

Cuban Neuroscience Center(Current)

Elea (Argentina)

National University of Quilmes

Centro de Ingeniería Genética y Biotecnología

Agueda Santana is an author at Cuban Neuroscience Center specializing in cell signaling, signal transduction, and medicine.

Top concepts

MedicineCell BiologyCell SignalingSignal TransductionCell DeathImmunologyProteomicsPharmacologyTumor BiologyDrug Discovery

Publications per year

2008–2011

3

Publications

3

CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo

Silvio E. Perea, Osvaldo Reyes, Idania Baladrón et al. · Molecular and Cellular Biochemistry · 2008 · 99 citations

Ck2 Phosphorylation, Novel Proapoptotic Peptide, Signal Transduction +11

Safety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies

Ana M. Solares, Agueda Santana, Idania Baladrón et al. · BMC Cancer · 2009 · 80 citations · Full text

CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research

Silvio E. Perea, Idania Baladrón, Yanelda García et al. · Molecular and Cellular Biochemistry · 2011 · 43 citations

Molecular Pharmacology, Signal Transduction, Ck2 Phosphoaceptor Domain +12

Rows per page

1–3 of 3